coronavirus
A scientist’s opinion : Interview with Dr Juan Pablo Horcajada about covid-19 treatment
Interview with Juan Pablo Horcajada, MD. is Head of the Department of Infectious Diseases and General Coordinator of the COVID-19 Service at the Hospital del Mar, Barcelona. Remdesivir is the first drug approved by the EMA to be used as part of the treatment of COVID-19 patients. How’s the use of this antiviral in your ...
Climate change & storytelling: challenges for the (post) Covid-19 era
End of 2019: Climate change, technological innovation and sustainability are among the priority subjects for the ESMH to cover. They get increasing attention in the media and they have a prominent place in the EU policy agenda. End of May 2020: European Parliament, Strasbourg: a hundred of young enthusiastic science communicators are supposed to attend ...
A scientist’s opinion : Interview with Prof Massimo Galli about covid-19 treatment
Massimo Galli is Professor of Infectious Diseases, Director of the Department of Biomedical and Clinical Sciences Luigi Sacco, University of Milan, and Director of Infectious Diseases III Division, ASST Fatebenefratelli Sacco, Luigi Sacco Hospital, Milan, Italy. He is one of Italy’s leading COVID-19 experts. He has published hundreds of scientific articles in international peer-reviewed journals. ...
Dexamethasone : the first life-saving drug for COVID-19 patients
Clinical trials make it possible to evaluate whether a treatment improves outcomes. Developing a hypothesis, for example if treatment A is better than standard treatment B, clinical trials enable understanding of the role of an intervention in improving patient care. In the current search for a successful treatment against COVID-19, ongoing multiple clinical trials have started to make a difference, such as the Recovery clinical trial on dexamethasone, which has given a definitive verdict on the use of corticosteroids during COVID-19.
A scientist’s opinion : Interview with Prof Martin Landray about covid-19 treatment
Interview with Martin Landray, Professor of Medicine and Epidemiology at the Nuffield Department of Population Health, University of Oxford, Oxford, UK. He is one of the main researchers participating in the Recovery study on dexamethasone. The study was published in the New England Journal of Medicine on 17 July 2020. What are the main conclusions ...
COVID-19 and Climate Change: connected crises and lessons to learn
The COVID-19 pandemic brought about worldwide disruption. As societies tentatively begin to reopen, the pandemic holds lessons for how the world faces another globally existential threat, the climate crisis.
A scientist’s opinion : Interview with Dr Diarmid Campbell-Lendrum about Covid-19 & climate crisis
Interview with Dr Diarmid Campbell-Lendrum, head of the climate change and health programme at WHO Headquarters. In what ways are the Covid-19 and climate crises similar in how they affect people and their health? Diarmid Campbell-Lendrum: Climate change in itself doesn’t cause COVID-19. We expect that weather, climate and seasonal variation may moderate transmission, but ...
A scientist’s opinion : Interview with Dr Debbie Rosen & Professor Piers Forster about Covid-19 & climate crisis
Interview with Dr Debbie Rosen, Science and Policy Manager for the EU Horizon 2020 CONSTRAIN project, based at the University of Leeds, UK, and Prof Piers Forster, professor of climate physics at the University of Leeds, the founding Director of the Priestley International Centre for Climate and PI for the CONSTRAIN project Global economic activity ...
